Molecular docking analyses suggested that osthole could not compete with MRGPRX2 agonists, but rather regulated MRGPRX2 activation through allosteric modification, mainly by attenuating Ca2+ mobilization in vitro and inhibiting inflammation in mouse models of pseudo-allergy.73 The gene discussed is MRGPRX2; the disease is Allergy.